Prostate Cancer Clinical Trials in Austin, TX

Prostate Cancer Clinical Trials in Austin, TX

View the best 10 prostate cancer medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Austin, Texas

Here are the top 10 medical studies for prostate cancer in Austin, Texas

Image of Weill Cornell Medical College in New York, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug, NGM831, as a possible treatment for advanced or metastatic solid tumors.
Image of University of Alabama at Birmingham (UAB) in Birmingham, United States.

Standard of Care Proton Therapy +3 More

Proton Beam Therapy

Recruiting1 award
This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.
Image of The Stamford Hospital in Stamford, United States.

Relugolix

Gonadotropin-Releasing Hormone (GnRH) Antagonist

Verified
Recruiting1 award
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Image of Houston Metro Urology in Houston, United States.

Radiotherapy +1 More

Radiation

Recruiting2 awardsPhase 3
This triallooks at if adding a drug to radiation and hormone therapy can delay the spread of cancer in the body.
Image of Mayo Clinic - Arizona in Phoenix, United States.

Rucaparib +3 More

PARP Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effects of rucaparib to those of other standard treatments for men with metastatic prostate cancer that has continued to grow despite castration and other treatments.
Image of Urological Associates of Southern Arizona in Tucson, United States.

Afuresertib +2 More

Protein Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a combination of two drugs, afuresertib and LAE001, to see if they are effective in treating patients with m-CRPC who have progressed/ become drug resistant following prior standard care treatments.
Image of Exelixis Clinical Site #4 in Tucson, United States.

Cabozantinib +1 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the safety and efficacy of cabozantinib in combination with atezolizumab versus a second novel hormonal therapy in men with mCRPC.
Image of Urologic Surgeons of Washington in Washington, United States.

HC-1119 +1 More

Antiandrogen

Recruiting2 awardsPhase 3
This trial is a study to compare the effectiveness and safety of a new oral medication, HC-1119, to a current standard of care medication, enzalutamide, in men with asymptomatic or mildly symptomatic prostate cancer that has progressed despite treatment with prior hormone therapy.
Image of The University of Arizona Cancer Center (UACC) - North Campus in Tucson, United States.

SM08502

Chemotherapy

Recruiting1 awardPhase 1
This trial is testing a new drug, SM08502, for safety and effectiveness in treating advanced solid tumors, either alone or in combination with other cancer treatments.

Popular filter options for prostate-cancer austin trials

Phase 3 Clinical Trials

View 64 phase 3 medical studies.

Clinical Trials With No Placebo

View 64 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.